Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 6 (2009), Issue 7 (July)

1. Gustatory and olfactory function in patients with unipolar and bipolar depression.
   Prog Neuropsychopharmacol Biol Psychiatry, 33(5): 827-34. [Abstract] [Full-text]
2. Association analysis of Group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.
   Prog Neuropsychopharmacol Biol Psychiatry, 33(5): 875-9. [Abstract] [Full-text]
3. Patterns of neurocognitive impairment in first-episode bipolar disorder and schizophrenia.
   Br J Psychiatry, 195(1): 67-72. [Abstract] [Full-text]
4. Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept.
   Br J Psychiatry, 195(1): 23-9. [Abstract] [Full-text]
5. Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study.
   Psychiatry Clin Neurosci, 63(3): 401-9. [Abstract] [Full-text]
6. Risk factors for obstructive sleep apnea syndrome screening in mood disorder patients.
   Psychiatry Clin Neurosci, 63(3): 385-91. [Abstract] [Full-text]
7. Altered prefrontal lobe oxygenation in bipolar disorder: a study by near-infrared spectroscopy.
   Psychol Med, 39(8): 1265-75. [Abstract] [Full-text]
8. Mental capacity, diagnosis and insight in psychiatric in-patients: a cross-sectional study.
   Psychol Med, 39(8): 1389-98. [Abstract] [Full-text]
9. Neurocognitive impairment in unaffected siblings of youth with bipolar disorder.
   Psychol Med, 39(8): 1253-63. [Abstract] [Full-text]
10. Mood lability and psychopathology in youth.
    Psychol Med, 39(8): 1237-45. [Abstract] [Full-text]
11. Set shifting and reversal learning in patients with bipolar disorder or schizophrenia.
    Psychol Med, 39(8): 1289-93. [Abstract] [Full-text]
12. Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding.
    Psychol Med, 39(8): 1231-5. [Abstract] [Full-text]
13. Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley Bipolar Twin and Family Study.
    Psychol Med, 39(8): 1277-87. [Abstract] [Full-text]
14. Age transitions in the course of bipolar I disorder.
    Psychol Med, 39(8): 1247-52. [Abstract] [Full-text]
15. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study.
    Am J Psychiatry, 166(7): 795-804. [Abstract] [Full-text]
16. Changes in gyrification over 4 years in bipolar disorder and their association with the brain-derived neurotrophic factor valine(66) methionine variant.
    Biol Psychiatry, 66(3): 293-7. [Abstract] [Full-text]
17. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression.
    Biol Psychiatry, 66(3): 223-30. [Abstract] [Full-text]
18. Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder.
    Biol Psychiatry, 66(3): 298-301. [Abstract] [Full-text]
19. Limbic and corpus callosum aberrations in adolescents with bipolar disorder: a tract-based spatial statistics analysis.
    Biol Psychiatry, 66(3): 238-44. [Abstract] [Full-text]
20. Evidence that variation in the oligodendrocyte lineage transcription factor 2 (OLIG2) gene is associated with psychosis in Alzheimer's disease.
    Neurosci Lett, 461(1): 54-9. [Abstract] [Full-text]
21. Clinical presentation of mania compared with depression: data from a geriatric clinic in India.
    Int Psychogeriatr, 21(4): 764-7. [Abstract] [Full-text]
22. Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population.
    Neuromolecular Med, 11(2): 114-22. [Abstract] [Full-text]
23. Matrix metalloproteinase-9 gene and bipolar mood disorder.
    Neuromolecular Med, 11(2): 128-32. [Abstract] [Full-text]
24. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
    Neurobiol Dis, 35(2): 165-76. [Abstract] [Full-text]
25. GSK3beta, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at serine-9.
    Neurobiol Dis, 35(2): 193-200. [Abstract] [Full-text]
26. Long-acting risperidone: a review of its role in the treatment of bipolar disorder.
    Adv Ther, 26(6): 588-99. [Abstract] [Full-text]
27. Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk.
    J Headache Pain, 10(4): 283-90. [Abstract] [Full-text]
28. Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder.
    Arch Gen Psychiatry, 66(7): 748-55. [Abstract] [Full-text]
29. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder.
    Arch Gen Psychiatry, 66(7): 713-20. [Abstract] [Full-text]
30. No evidence for excess runs of homozygosity in bipolar disorder.
    Psychiatr Genet, 19(4): 165-70. [Abstract] [Full-text]
31. Bipolar Disorder: an impossible diagnosis.
    Clin Pract Epidemol Ment Health, 5: 13. [Abstract] [Full-text]
32. Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study.
    Pharmacopsychiatry, 42(4): 145-52. [Abstract] [Full-text]
33. Chronic toxicology of cannabis.
    Clin Toxicol (Phila), 47(6): 517-24. [Abstract] [Full-text]
34. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder.
    Am J Hum Genet, 85(1): 13-24. [Abstract] [Full-text]
35. Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction?
    Expert Rev Neurother, 9(7): 1045-58. [Abstract] [Full-text]
36. Clinical implications of a staging model for bipolar disorders.
    Expert Rev Neurother, 9(7): 957-66. [Abstract] [Full-text]
37. Corpus callosum abnormalities in pediatric bipolar disorder.
    Expert Rev Neurother, 9(7): 949-55. [Abstract] [Full-text]
38. Hydrotherapy in state mental hospitals in the mid-twentieth century.
    Issues Ment Health Nurs, 30(8): 491-4. [Abstract] [Full-text]
39. Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico.
    J Clin Psychopharmacol, 29(4): 358-61. [Abstract] [Full-text]
40. Exploration of the one-bead one-compound methodology for the design of prolyl oligopeptidase substrates.
    PLoS One, 4(7): e6222. [Abstract] [Full-text]
41. Creating zinc monkey wrenches in the treatment of epigenetic disorders.
    Curr Opin Chem Biol, 13(3): 263-71. [Abstract] [Full-text]
42. A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study.
    Schizophr Res, 113(1): 41-8. [Abstract] [Full-text]
43. Performance-based and subjective measures of functioning in middle-aged and older adults with bipolar disorder.
    J Nerv Ment Dis, 197(7): 471-5. [Abstract] [Full-text]
44. Cochrane Reviews of non-medication-based psychotherapeutic and other interventions for schizophrenia, psychosis, and bipolar disorder: A systematic literature review.
    Int J Ment Health Nurs, 18(4): 239-49. [Abstract] [Full-text]
45. Suicide risk in rapid cycling bipolar patients.
    J Affect Disord, 117(1): 74-8. [Abstract] [Full-text]
46. A community survey of the twelve-month prevalence and correlates of bipolar spectrum disorder in Hong Kong.
    J Affect Disord, 117(1): 79-86. [Abstract] [Full-text]
47. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan.
    J Affect Disord, 117(1): 124-9. [Abstract] [Full-text]
48. Criminal behaviour and violent crimes in former inpatients with affective disorder.
    J Affect Disord, 117(1): 98-103. [Abstract] [Full-text]
49. Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population.
    J Affect Disord, 117(1): 87-97. [Abstract] [Full-text]
50. Erectile dysfunction in a sample of patients attending a psychiatric outpatient department.
    Int J Impot Res, 21(4): 235-9. [Abstract] [Full-text]
51. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder.
    Psychosom Med, 71(6): 598-606. [Abstract] [Full-text]
52. Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study.
    World J Biol Psychiatry. [Abstract] [Full-text]
53. Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation.
    Psychopharmacology (Berl), 205(3): 419-29. [Abstract] [Full-text]
54. Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice.
    Psychopharmacology (Berl), 205(3): 369-77. [Abstract] [Full-text]
55. Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice.
    Mol Brain, 2(1): 19. [Abstract] [Full-text]
56. Reflective and ruminative processing of positive emotional memories in bipolar disorder and healthy controls.
    Behav Res Ther, 47(8): 697-704. [Abstract] [Full-text]
57. Site-specific regulation of cell cycle and DNA repair in post-mitotic GABA cells in schizophrenic versus bipolars.
    Proc Natl Acad Sci U S A, 106(28): 11731-6. [Abstract] [Full-text]
58. Preliminary evidence on the association between XBP1-116C/G polymorphism and response to prophylactic treatment with valproate in bipolar disorders.
    Psychiatry Res, 168(3): 209-12. [Abstract] [Full-text]
59. Lipid levels in female patients with affective disorders.
    Psychiatry Res, 168(3): 218-21. [Abstract] [Full-text]
60. Subcortical volumetric correlates of anxiety in familial pediatric bipolar disorder: a preliminary investigation.
    Psychiatry Res, 173(2): 113-20. [Abstract] [Full-text]
61. Longer-term treatment of patients with bipolar disorder: a 9-month observational study in Central and Eastern Europe, the Middle East and Africa.
    Curr Med Res Opin, 25(8): 1889-900. [Abstract] [Full-text]
62. Association of genetic polymorphisms in the type II deiodinase gene with bipolar disorder in a subset of Chinese population.
    Prog Neuropsychopharmacol Biol Psychiatry, 33(6): 986-90. [Abstract] [Full-text]
63. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions.
    Neurosci Res, 65(1): 35-43. [Abstract] [Full-text]
64. Genetics of psychosis; insights from views across the genome.
    Hum Genet, 126(1): 3-12. [Abstract] [Full-text]
65. Corpus callosum size and shape alterations in individuals with bipolar disorder and their first-degree relatives.
    Prog Neuropsychopharmacol Biol Psychiatry, 33(6): 1050-7. [Abstract] [Full-text]
66. Oxidative imbalance in bipolar disorder subtypes: a comparative study.
    Prog Neuropsychopharmacol Biol Psychiatry, 33(6): 1070-4. [Abstract] [Full-text]
67. Treatment-refractory bipolar disorder: classification to aid in clinical management.
    Expert Opin Pharmacother, 10(12): 1907-15. [Abstract] [Full-text]
68. Indirect measurement of dysfunctional attitudes in bipolar affective disorder.
    Psychol Psychother, 82: 261-6. [Abstract] [Full-text]
69. Adult attachment in bipolar 1 disorder.
    Psychol Psychother, 82: 267-77. [Abstract] [Full-text]
70. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.
    Prog Neurobiol, 88(4): 264-71. [Abstract] [Full-text]
71. Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype.
    Eur J Hum Genet, 17(8): 1034-42. [Abstract] [Full-text]
72. Genome-wide association study of bipolar disorder in European American and African American individuals.
    Mol Psychiatry, 14(8): 755-63. [Abstract] [Full-text]
73. Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL/lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus.
    Basic Clin Pharmacol Toxicol, 105(2): 113-9. [Abstract] [Full-text]
74. Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania.
    Int J Clin Pract, 63(8): 1249-58. [Abstract] [Full-text]
75. Neuropsychological functions in patients with bipolar I and bipolar II disorder.
    Bipolar Disord, 11(5): 547-54. [Abstract] [Full-text]
76. Difference in binocular rivalry rate between patients with bipolar I and bipolar II disorders.
    Bipolar Disord, 11(5): 539-46. [Abstract] [Full-text]
77. Remission from mania is associated with a decrease in amygdala activation during motor response inhibition.
    Bipolar Disord, 11(5): 530-8. [Abstract] [Full-text]
78. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia.
    Bipolar Disord, 11(5): 523-9. [Abstract] [Full-text]
79. Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue.
    Bipolar Disord, 11(5): 515-22. [Abstract] [Full-text]
80. Microstructural white matter changes in euthymic bipolar patients: a whole-brain diffusion tensor imaging study.
    Bipolar Disord, 11(5): 504-14. [Abstract] [Full-text]
81. Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients.
    Bipolar Disord, 11(5): 494-503. [Abstract] [Full-text]
82. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    Bipolar Disord, 11(5): 483-93. [Abstract] [Full-text]
83. Psychological therapies in bipolar disorder: the effect of illness history on relapse prevention - a systematic review.
    Bipolar Disord, 11(5): 474-82. [Abstract] [Full-text]
84. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.
    Bipolar Disord, 11(5): 453-73. [Abstract] [Full-text]
85. Abnormal hippocampal distribution of TDP-43 in patients with-late onset psychosis.
    Aust N Z J Psychiatry, 43(8): 739-45. [Abstract] [Full-text]
86. Protective effects of lithium on acetic acid-induced colitis in rats.
    Dig Dis Sci, 54(9): 1901-7. [Abstract] [Full-text]
87. Phosphorylation status of glucocorticoid receptor, heat shock protein 70, cytochrome c and Bax in lymphocytes of euthymic, depressed and manic bipolar patients.
    Psychoneuroendocrinology, 34(8): 1162-75. [Abstract] [Full-text]
88. The role of general intelligence as an intermediate phenotype for neuropsychiatric disorders.
    Cogn Neuropsychiatry, 14(4): 299-311. [Abstract] [Full-text]
89. The NGL family of leucine-rich repeat-containing synaptic adhesion molecules.
    Mol Cell Neurosci, 42(1): 1-10. [Abstract] [Full-text]
90. Heartache of the state, enemy of the self: bipolar disorder and cultural change in urban China.
    Cult Med Psychiatry, 33(3): 421-50. [Abstract] [Full-text]
91. Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future.
    Hum Mutat, 30(8): 1139-52. [Abstract] [Full-text]
92. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?
    Neurotoxicology, 30(4): 497-521. [Abstract] [Full-text]
93. The effects of crisis plans for patients with psychotic and bipolar disorders: a randomised controlled trial.
    BMC Psychiatry, 9: 41. [Abstract] [Full-text]
94. Predicting juvenile delinquency: The nexus of childhood maltreatment, depression and bipolar disorder.
    Crim Behav Ment Health. [Abstract] [Full-text]
95. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
    Pharmacotherapy, 29(8): 975-87. [Abstract] [Full-text]
96. Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia.
    Behav Brain Funct, 5: 28. [Abstract] [Full-text]
97. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation.
    Clin Neuropharmacol, 32(4): 199-204. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.